chaga
diseas
cd
neglect
infecti
diseas
caus
intracellular
protozoan
parasit
trypanosoma
cruzi
cd
affect
five
million
peopl
latin
america
anoth
million
risk
acquir
approxim
new
case
report
occur
year
approxim
patient
die
human
migrat
contribut
substanti
current
global
scenario
cd
increas
number
case
nonendem
countri
epidemiolog
econom
social
implic
challeng
control
spread
annual
cost
due
cd
global
us
billion
lifetim
cost
us
per
infect
although
individu
infect
cruzi
remain
asymptomat
lifelong
approxim
infect
individu
progress
year
symptomat
form
diseas
develop
either
chronic
chagas
cardiomyopathi
ccc
digest
megasyndrom
patient
develop
lethal
cardiomyopathi
heart
transplant
remain
ultim
treatment
ccc
inflammatori
condit
character
intens
immun
initi
infect
proinflammatori
cytokin
produc
product
continu
along
chronic
phase
like
due
parasit
persist
among
persist
respons
lead
cardiac
commit
start
myocard
progress
transmiss
pathogen
triatomin
insect
vector
subfamili
triatomina
cruzi
use
sever
mechan
escap
host
immun
respons
among
evas
complement
infect
form
cruzi
metacycl
trypomastigot
invad
almost
nucleat
involv
wide
divers
receptor
kinin
receptor
tyrosin
kinas
transform
epiderm
growth
factor
receptor
lectin
receptor
fibronectin
tolllik
addit
receptor
cruzi
util
complement
molecul
promot
phagocytosi
lectin
protein
mannosebind
lectin
mbl
evad
host
immun
attack
promot
evansoss
collabor
suggest
deposit
mbl
cruzi
parasit
surfac
play
role
infect
process
parasit
deactiv
lectin
complement
ultim
could
favor
cruzi
cell
intern
mediat
receptor
molecul
includ
complement
system
essenti
innat
acquir
contribut
immunopathogenesi
varieti
diseas
includ
multifunct
polymorph
glycoprotein
occur
solubl
transmembran
protein
express
peripher
blood
cell
includ
monocyt
erythrocyt
natur
killer
cell
well
b
known
enhanc
phagocytosi
particl
opson
mbl
well
facilit
clearanc
immun
complex
bind
erythrocyt
macrophag
gene
locat
chromosom
omim
belong
regul
complement
activ
famili
character
small
consensu
repeat
also
known
complement
control
protein
genet
variabl
may
influenc
express
includ
molecular
weight
densiti
molecul
cell
demonstr
involv
pathogenesi
sever
infecti
diseas
either
facilit
pathogen
entri
host
cell
case
downmodul
complement
activ
shown
mediat
immun
opson
leishmania
amastigot
plasmodium
mycobacterium
hepat
c
west
nile
besid
role
facilit
entri
intracellular
pathogen
host
cell
protein
level
shown
associ
pathogenesi
differ
diseas
includ
lepromat
sever
acut
respiratori
chronic
liver
hiv
infect
among
genet
variant
exon
evalu
studi
particular
interest
sinc
nonsynonym
variant
http
wwwensemblorg
situat
bind
site
ficolin
mbl
therebi
potenti
influenc
complement
induc
present
studi
aim
assess
genet
variant
exon
level
associ
develop
clinic
present
chronic
cd
plasma
level
significantli
lower
cd
patient
compar
control
p
fig
compar
control
clinic
form
separ
statist
differ
also
observ
level
control
indetermin
form
p
cardiac
form
p
digest
form
p
cardiodigest
form
p
fig
comparison
level
asymptomat
indetermin
form
symptomat
patient
show
statist
differ
distribut
genotyp
control
hardyweinberg
equilibrium
p
patient
chronic
cd
three
snp
hw
equilibrium
may
due
diseas
associ
frequenc
variant
p
ci
p
ci
p
ci
significantli
higher
cd
patient
compar
control
tabl
also
frequenc
genotyp
p
ci
p
ci
significantli
higher
chronic
cd
patient
control
tabl
analyz
cd
patient
accord
clinic
present
relat
control
allel
occur
frequent
among
asymptomat
indetermin
form
cd
p
ci
patient
present
digest
form
cd
p
ci
tabl
addit
carrier
g
allel
rather
present
among
asymptomat
patient
control
p
ci
tabl
signific
associ
cardiac
form
found
also
minor
g
allel
p
ci
g
carrier
ag
gg
p
ci
tabl
patient
cardiomyopathi
grade
accord
classif
cardiomyopathi
outlin
method
section
compar
asymptomat
patient
allel
occur
frequent
patient
cardiomyopathi
without
echo
alter
p
ci
patient
cardiomyopathi
without
heart
failur
p
ci
asymptomat
patient
genotyp
observ
frequent
among
patient
cardiomyopathi
without
echo
alter
p
ci
patient
cardiomyopathi
without
heart
failur
p
ci
patient
without
overt
symptom
tabl
compar
patient
cardiomyopathi
consid
differ
stage
cardiac
patholog
allel
p
ci
genotyp
p
ci
frequent
patient
without
heart
failur
heart
failur
tabl
total
haplotyp
observ
reconstruct
six
variant
investig
studi
fig
frequenc
agagtg
haplotyp
significantli
increas
among
cd
patient
p
ci
patient
cardiomyopathi
without
echo
alter
p
ci
cardiomyopathi
patient
without
heart
failur
p
ci
among
control
addit
agggtg
significantli
associ
cardiomyopathi
p
ci
absenc
heart
failur
p
ci
comparison
control
tabl
linkag
disequilibrium
ld
pattern
variant
given
fig
strong
ld
observ
chronic
cd
patient
ld
plot
indic
strong
ld
therefor
also
strong
ld
order
maintain
life
cycl
transmiss
triatomin
vector
human
host
cruzi
need
evad
host
immun
attack
develop
intracellularli
success
entranc
cruzi
host
cell
depend
downregul
complement
activ
parasit
regulatori
molecul
bind
complement
receptor
thu
complement
system
import
role
establish
cruzi
infect
susten
chronic
phase
studi
genet
variant
exon
investig
patient
chronic
cd
order
assess
role
modul
level
well
develop
clinic
progress
diseas
patient
chronic
cd
significantli
decreas
level
compar
healthi
control
plasma
level
observ
control
group
accord
report
reduc
express
erythrocyt
combin
increas
level
immun
complex
demonstr
pathogenesi
hiv
sarscov
tuberculosi
lepra
leprosi
aid
tuberculosi
reduct
level
diseas
regul
demonstr
condit
acquir
rather
moreov
known
similarli
mechan
use
pathogen
cruzi
use
promot
phagocytosi
well
mbl
promot
opson
via
strategi
evad
host
immun
system
infect
host
interestingli
patient
cardiomyopathi
lower
plasma
level
asymptomat
patient
might
indic
either
consumpt
due
increas
complement
activ
lower
product
associ
clinic
manifest
fact
chagas
cardiomyopathi
known
associ
inflammatori
process
tissu
damag
observ
variou
inflammatori
infecti
moreov
one
consequ
persist
myocardi
damag
cd
left
ventricular
dilat
systol
reason
left
ventricular
systol
function
evalu
cd
patient
use
left
ventricular
eject
fraction
lvef
despit
import
role
complement
system
cardiovascular
myocardi
acut
ischaem
correl
level
lvef
found
find
corrobor
data
studi
patient
acut
myocardi
known
level
may
influenc
infect
express
associ
genet
well
acquir
observ
studi
lower
level
associ
genotyp
control
patient
two
studi
found
genotyp
associ
lower
erythrocyt
sediment
preterm
find
indic
genotyp
may
modul
express
sinc
associ
level
patient
reduct
level
chronic
cd
probabl
due
diseas
process
antiinflammatori
role
alreadi
observ
experiment
studi
abl
prevent
tissu
injuri
induc
complement
consid
chronic
cd
associ
inflamm
possibl
low
level
cd
patient
may
relat
antiinflammatori
effect
consumpt
due
complement
activ
howev
exact
mechan
control
express
cd
patient
still
unclear
posit
associ
ag
gg
genotyp
variant
g
allel
variant
observ
chronic
cd
may
relat
function
properti
molecul
variant
lead
substitut
amino
acid
molecul
may
affect
fold
affin
allel
also
relat
low
ratio
express
erythrocyt
addit
allel
previous
associ
sever
sickl
cell
show
protect
effect
tuberculosi
allel
increas
risk
alzheim
gastric
nonsmal
cell
lung
preterm
moreov
allel
agggtg
agagtg
haplotyp
relat
earli
stage
cd
cardiac
form
indic
variant
might
predispos
clinic
progress
chronic
patient
cd
sinc
pathogenesi
ccc
involv
parasit
persist
differ
tissu
well
continu
lowgrad
parasitemia
inflammatori
process
immun
mediatedmyocardi
injuri
possibl
protein
product
variant
may
augment
cruzi
bind
consequ
cellular
intern
besid
immunomodulatori
effect
limit
present
studi
lack
baselin
plasma
level
patient
acut
cd
acut
cd
patient
difficult
diagnos
clinic
henc
measur
level
possibl
earli
stage
infect
might
serv
baselin
measur
ambulatori
chaga
diseas
hospit
da
feder
univers
enrol
chronic
cd
patient
thu
make
access
acut
cd
patient
imposs
conclus
studi
report
variant
associ
risk
cruzi
infect
progress
chagas
cardiomyopathi
besid
low
level
observ
cd
patient
possibl
due
diseas
process
first
studi
provid
insight
role
develop
clinic
present
chronic
cd
nevertheless
studi
necessari
confirm
find
total
chronic
cd
patient
attend
ambulatori
chaga
diseas
hospit
da
feder
univers
investig
mean
age
year
femal
male
euro
afrobrazilian
asian
amerindian
cd
diagnosi
perform
two
serolog
test
elisa
immunofluoresc
antibodi
assay
clinic
find
accord
outlin
panamerican
health
organ
paho
world
health
organ
clinic
detail
patient
obtain
medic
record
interview
patient
younger
year
old
recent
infect
suspect
nonchagas
cardiomyopathi
exclud
demograph
clinic
characterist
distinct
cd
form
shown
tabl
patient
cardiomyopathi
grade
accord
cardiac
insuffici
classif
american
heart
associ
adapt
alter
electrocardiogram
ecg
normal
echocardiogram
echo
absenc
cardiac
insuffici
ci
alter
ecg
lvef
absenc
ci
alter
echo
lvef
absenc
ci
c
alter
ecg
echo
compens
ci
alter
ecg
echo
refractori
ci
group
healthi
brazilian
mean
age
year
femal
male
euro
afrobrazilian
asian
amerindian
use
control
individu
control
group
select
consecut
blood
bank
geograph
region
patient
follow
brazilian
health
regul
blood
donor
screen
cd
syphili
hepat
b
hepat
c
hiv
human
tcell
lymphotrop
virus
use
high
sensit
assay
addit
inform
autoimmun
diseas
cancer
background
obtain
preselect
studi
protocol
approv
ethic
committe
hospit
de
feder
univers
cephcufpr
n
perform
accord
relev
guidelinesregul
written
inform
consent
obtain
patient
control
order
assess
distribut
six
function
exon
variant
g
g
g
g
g
entir
exon
includ
intronexon
boundari
directli
sequenc
patient
chronic
cd
healthi
control
individu
dna
patient
two
control
degrad
therefor
individu
exclud
genet
analys
genom
dna
extract
buffycoat
use
qiaamp
blood
mini
kit
qiagen
gmbh
hilden
germani
follow
manufactur
instruct
refer
sequenc
retriev
ensembl
databas
wwwensemblorg
primer
target
exon
gene
design
manual
test
use
primerblast
http
wwwncbinlmnihgovtoolsprimerblast
synthes
commerci
eurofin
genom
ebersberg
germani
fragment
bp
amplifi
polymeras
chain
reaction
pcr
use
locu
specif
primer
pair
tca
taa
ata
atg
cca
gaa
gtg
caa
ttt
cat
agt
cct
tat
aca
pcr
amplif
carri
volum
reaction
mixtur
contain
pcr
buffer
mm
mm
dntp
primer
unit
taq
polymeras
qiagen
ng
genom
dna
tprofession
basic
thermocycl
biometra
gmbh
germani
cycl
paramet
initi
denatur
minut
follow
cycl
denatur
second
anneal
second
elong
minut
final
elong
step
minut
pcr
fragment
stain
sybr
safe
dna
gel
stain
invitrogen
carlsbad
usa
visualis
agaros
gel
pcr
product
purifi
use
exosapit
usbaffymetrix
santa
clara
usa
purifi
product
directli
use
templat
sequenc
use
bigdy
termin
cycl
sequenc
kit
appli
biosystem
texa
usa
abi
dna
analyz
dna
polymorph
identifi
assembl
sequenc
refer
sequenc
use
geneiou
softwar
biomatt
ltd
auckland
new
zealand
reconfirm
visual
respect
electropherogram
measur
erythrocyt
plasma
level
perform
patient
control
use
commerci
highsensit
elisa
kit
human
complement
receptor
cloudclon
corpor
texa
usa
accord
manufactur
instruct
limit
detect
ngml
plasma
level
compar
group
use
nonparametr
kruskalw
mannwhitney
test
distribut
variabl
assess
shapirowilk
test
multipl
logist
regress
execut
adjust
age
sex
ethnic
group
multipl
comparison
correct
use
benjaminihochberg
procedur
appli
fals
discoveri
rate
raw
pvalu
remain
signific
correct
consid
studi
odd
ratio
confid
interv
ci
calcul
use
stata
softwar
v
statacorp
colleg
station
texa
usa
correl
analys
perform
nonparametr
spearman
rank
coeffici
test
allel
frequenc
obtain
direct
count
genotyp
haplotyp
frequenc
analyz
gene
count
expectationmaximum
em
algorithm
signific
deviat
hardyweinberg
equilibrium
test
use
randompermut
procedur
implement
arlequin
v
softwar
http
lgbunigecharlequin
linkag
disequilibrium
ld
analysi
perform
use
haploview
v
http
broadinstituteorghaploview
possibl
associ
allel
genotyp
haplotyp
differ
clinic
form
evalu
twotail
fisher
exact
test
pvalu
consid
signific
